Vignesh Rajah's most recent trade in Y-Mabs Therapeutics Inc was a trade of 1,711 Common Stock done at an average price of $16.5 . Disclosure was reported to the exchange on March 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | 05 Mar 2024 | 1,711 | 33,889 (0%) | 0% | 16.5 | 28,283 | Common Stock | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | 18 Jan 2024 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | 18 Jan 2024 | 17,800 | 35,600 (0%) | 0% | 0 | Common Stock | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | 26 Jan 2023 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | 17 Jan 2023 | 35,700 | 35,700 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CHIEF MEDICAL OFFICER | 17 Jan 2023 | 17,800 | 17,800 (0%) | 0% | 0 | Common Stock | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | 15 Nov 2022 | 1,195 | 4,266 (0%) | 0% | 4.9 | 5,884 | Common Stock | |
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | 26 Apr 2022 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | 14 Dec 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (right to buy) | ||
| Y-Mabs Therapeutics Inc | Vignesh Rajah | SVP & CMO | 12 Aug 2021 | 1,374 | 3,071 (0%) | 0% | 29.9 | 41,147 | Common Stock |